Investigating how microglial lipoprotein lipase affects Alzheimer's disease
Targeting Microglial Lipoprotein Lipase in Alzheimer's disease
This study is looking at how a brain enzyme called lipoprotein lipase (LPL) might help clear away harmful proteins linked to Alzheimer's disease, with the hope of finding new ways to prevent or slow down the condition for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado Denver NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project ID | NIH-11092213 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of microglial lipoprotein lipase (LPL) in Alzheimer's disease (AD), a severe neurodegenerative disorder. The study aims to explore how LPL, an enzyme that helps process lipoproteins in the brain, can influence the clearance of amyloid-beta, a protein that accumulates in the brains of AD patients. By examining the mechanisms of LPL in microglia, the research seeks to identify potential therapeutic targets that could help prevent or delay the onset of AD. Patients may benefit from insights gained about LPL's protective role against amyloid plaque formation.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk for Alzheimer's disease, particularly those with genetic factors that may influence lipoprotein metabolism.
Not a fit: Patients with advanced Alzheimer's disease or those who do not have any genetic predisposition to the condition may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies that slow down or prevent the progression of Alzheimer's disease.
How similar studies have performed: Previous studies have shown promising results in targeting lipoprotein metabolism for Alzheimer's treatment, suggesting that this approach may be viable.
Where this research is happening
Aurora, UNITED STATES
- University of Colorado Denver — Aurora, United States (Active)
Researchers
- Principal investigator: Bruce, Kimberley D — University of Colorado Denver
- Study coordinator: Bruce, Kimberley D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.